|Bid||0.36 x 1000|
|Ask||0.55 x 1000|
|Day's Range||0.38 - 0.41|
|52 Week Range||0.32 - 3.90|
|PE Ratio (TTM)||-0.23|
|Earnings Date||Nov 13, 2017 - Nov 17, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||26.25|
SEATTLE, Aug. 14, 2017-- Atossa Genetics Inc. today announced Second Quarter ended June 30, 2017 financial results and provided an update on recent company developments.. Steve Quay, President and CEO, ...
Topics Include: Monthly Macroeconomic Commentary, Investment Considerations, Biotechnology, Cloud Services, Energy, Fintech, Healthcare Insurance, SaaS, Technology, and More SAN FRANCISCO, CA / ACCESSWIRE ...
SEATTLE, July 25, 2017-- Atossa Genetics Inc., a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, has now completed ...